Metagenomic Sequencing Market to Observe Fastest Growth in Asia-Pacific

The metagenomic sequencing market was USD 1,938 million in 2022, and it will reach USD 6,899 million, advancing at a 17.20% compound annual growth rate, by 2030.

The growth in the industry is because of the decreasing cost of this technique. Furthermore, the implementation of this technique is increasing in agricultural biotechnology, where it allows the analysis of the whole genome in an environmental sample without the need for culturing.

Request for sample pages of this report: https://www.psmarketresearch.com/market-analysis/metagenomic-sequencing-market/report-sample

In 2022, the drug discovery category, based on application, held the largest share, of over 26%, and it will remain the largest in the years to come. This is because of the rising activities of research in the biotechnical and pharmaceutical industries for novel drug discovery, regularly as part of partnerships between academic institutes and industry players.

Top Providers of Metagenomic Sequencing Solutions Are:
• Illumina Inc.
• Thermo Fisher Scientific
• PerkinElmer Inc.
• Oxford Nanopore Technologies Plc
• QIAGEN N.V.
• F. Hoffmann-La Roche Ltd.
• Novogene Co. Ltd.
• Swift Biosciences Inc.
• Agilent Technologies Inc.

In 2022, North America accounted for the largest share, of over 42%, and it will observe a strong growth rate in the years to come. This is because of the higher risk of illnesses, extensive R&D activities in the pharmaceutical and biotechnology sectors, ad full-bodied support for the setup of new R&D facilities, and the presence of reputable healthcare businesses in the continent.

Whereas, APAC will observe the fastest growth rate in the years to come. This is because of the surging investment by domestic and international businesses, government support for research in advanced healthcare areas, development of the healthcare infrastructure, and a large pool of patients with infectious and chronic illnesses.

Make inquiry before purchase of this report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=metagenomic-sequencing-market

With the increasing incidence of genetic and infectious illnesses, as well as government investments in healthcare research and development, the metagenomic sequencing industry will continue to grow in the years to come.

Contact:
Chandra Mohan
AVP - Business Development
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarefuturetrends.blogspot.com

About P&S Intelligence

P&S Intelligence offers custom and syndicated market research and consulting services to clients across the globe. Our team of young and dynamic researchers, guided by mentors with years of experience, create data-rich reports tailored to the needs of MNCs as well as startups and SMEs. We remain in a perennial quest to offer exhaustive insights into every aspect of the market, allowing businesses of all sizes to seize even the smallest of opportunities and tackle even the biggest of challenges.

This release was published on openPR.